Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 1
1908 1
1910 1
1915 1
1929 2
1941 1
1946 1
1947 2
1948 2
1949 2
1950 20
1951 12
1952 10
1953 12
1954 16
1955 11
1956 13
1957 10
1958 16
1959 4
1960 5
1961 2
1962 2
1963 26
1964 24
1965 24
1966 16
1967 14
1968 16
1969 16
1970 18
1971 18
1972 18
1973 16
1974 18
1975 32
1976 33
1977 43
1978 32
1979 57
1980 29
1981 29
1982 26
1983 25
1984 38
1985 44
1986 33
1987 48
1988 44
1989 64
1990 64
1991 61
1992 68
1993 65
1994 79
1995 67
1996 108
1997 98
1998 105
1999 129
2000 175
2001 199
2002 210
2003 232
2004 300
2005 264
2006 285
2007 291
2008 326
2009 342
2010 400
2011 418
2012 455
2013 439
2014 461
2015 520
2016 611
2017 764
2018 1002
2019 1192
2020 1714
2021 2204
2022 2345
2023 2622
2024 3000
2025 3924
2026 752

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24,455 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: tivshenko
Page 1
Showing results for tivshenko io
Search for Timoshenko IO instead (1 results)
Immuno-Oncology Advances in Genitourinary Cancers.
Zang PD, Angeles A, Dorff TB, Pal SK, Gupta S. Zang PD, et al. Am Soc Clin Oncol Educ Book. 2024 Jan;44(2):e430428. doi: 10.1200/EDBK_430428. Am Soc Clin Oncol Educ Book. 2024. PMID: 38206274 Free article. Review.
In urothelial carcinoma, we discuss the growing use of IO including exciting recent updates with IO-based regimens that may soon become the new standard of care. We further discuss difficulties with IO in prostate cancer, germ cell tumors, and penile squamous …
In urothelial carcinoma, we discuss the growing use of IO including exciting recent updates with IO-based regimens that may so …
Intraosseous Vascular Access.
Dornhofer P, McMahon K, Kellar JZ. Dornhofer P, et al. 2025 May 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 May 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32119260 Free Books & Documents.
Compared to standard venous and central line access, IO placement is easier and faster, particularly in those who are critically ill. IO access is appropriate for all age groups, including preterm neonates. ...Nevertheless, any medication or fluid that can be admini …
Compared to standard venous and central line access, IO placement is easier and faster, particularly in those who are critically ill. …
Graphene nanostructures for input-output bioelectronics.
Garg R, Roman DS, Wang Y, Cohen-Karni D, Cohen-Karni T. Garg R, et al. Biophys Rev (Melville). 2021 Dec;2(4):041304. doi: 10.1063/5.0073870. Epub 2021 Dec 29. Biophys Rev (Melville). 2021. PMID: 35005709 Free PMC article. Review.
Institutional objection to abortion: A mixed-methods narrative review.
Merner B, Haining CM, Willmott L, Savulescu J, Keogh LA. Merner B, et al. Womens Health (Lond). 2023 Jan-Dec;19:17455057231152373. doi: 10.1177/17455057231152373. Womens Health (Lond). 2023. PMID: 36785871 Free PMC article. Review.
Further research is needed to explore whether IO is morally justified, how decisions are made to claim IO, and on what grounds. Finally, appropriate models for regulating IO are needed to ensure the protection of women's access to abortion. Such models could …
Further research is needed to explore whether IO is morally justified, how decisions are made to claim IO, and on what grounds …
Experimental animal modeling for immuno-oncology.
Li QX, Feuer G, Ouyang X, An X. Li QX, et al. Pharmacol Ther. 2017 May;173:34-46. doi: 10.1016/j.pharmthera.2017.02.002. Epub 2017 Feb 4. Pharmacol Ther. 2017. PMID: 28167217 Review.
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma.
Chen YW, Rini BI. Chen YW, et al. Curr Oncol Rep. 2022 Jun;24(6):695-702. doi: 10.1007/s11912-022-01196-1. Epub 2022 Mar 5. Curr Oncol Rep. 2022. PMID: 35247142 Free PMC article. Review.
Landmark trials of mccRCC are reviewed and perspective on treatment options is provided. RECENT FINDINGS: The four IO-based combinations reviewed are ipilimumab/nivolumab (IO/IO), pembrolizumab/axitinib (IO/TKI), nivolumab/cabozantinib (IO/TKI), …
Landmark trials of mccRCC are reviewed and perspective on treatment options is provided. RECENT FINDINGS: The four IO-based combinati …
Rational design and identification of immuno-oncology drug combinations.
Iafolla MAJ, Selby H, Warner K, Ohashi PS, Haibe-Kains B, Siu LL. Iafolla MAJ, et al. Eur J Cancer. 2018 May;95:38-51. doi: 10.1016/j.ejca.2018.02.027. Epub 2018 Apr 7. Eur J Cancer. 2018. PMID: 29631102 Review.
This study identified the current combination IO drug clinical trials and investigated how tumour molecular profiling can help rationalise IO drug combinations. ...Combination IO trials were obtained by searching doublet IO drug combinations in www.cli …
This study identified the current combination IO drug clinical trials and investigated how tumour molecular profiling can help ration …
From NaGa(IO(3))(3)F to NaGa(IO(3))(2)F(2) and NaGa(IO(3))(4): The Effects of Chemical Substitution between F(-) Anions and IO(3)(-) Groups on the Structures and Properties of Gallium Iodates.
Yang S, Wu H, Hu Z, Wang J, Wu Y, Yu H. Yang S, et al. Inorg Chem. 2024 Jan 15;63(2):1404-1413. doi: 10.1021/acs.inorgchem.3c03928. Epub 2024 Jan 1. Inorg Chem. 2024. PMID: 38163854
Herein, two new gallium iodates, NaGa(IO(3))(2)F(2) (1) and NaGa(IO(3))(4) (2), were successfully designed and synthesized based on NaGa(IO(3))(3)F by introducing more F(-) anions and replacing F(-) anions with IO(3) groups, respectively. ...While in c …
Herein, two new gallium iodates, NaGa(IO(3))(2)F(2) (1) and NaGa(IO(3))(4) (2), were successfully designed and synthesized bas …
Real world data on IO-based therapy for metastatic renal cell carcinoma.
Stühler V, Herrmann L, Rausch S, Stenzl A, Bedke J. Stühler V, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):3249-3258. doi: 10.1007/s00432-022-04173-0. Epub 2022 Jul 30. J Cancer Res Clin Oncol. 2023. PMID: 35907009 Free PMC article.
Progression-free (PFS) and overall survival (OS) were analyzed using descriptive statistics and Kaplan-Meier analysis. RESULTS: Over the years, IO-based therapies have increased significantly. The collective comprises 76 patients with first-line IO-based therapy ( …
Progression-free (PFS) and overall survival (OS) were analyzed using descriptive statistics and Kaplan-Meier analysis. RESULTS: Over the yea …
Io's Sodium Cloud.
Goldberg BA, Garneau GW, Lavoie SK. Goldberg BA, et al. Science. 1984 Nov 2;226(4674):512-6. doi: 10.1126/science.226.4674.512. Science. 1984. PMID: 17821495
The first two-dimensional images of the source region of Io's neutral sodium cloud have been acquired by ground-based observation. Observed asymmetries in its spatial brightness distribution provide new evidence that the cloud is supplied by sodium that is ejected nonisotr …
The first two-dimensional images of the source region of Io's neutral sodium cloud have been acquired by ground-based observation. Ob …
24,455 results
You have reached the last available page of results. Please see the User Guide for more information.